TIRZEPATIDE 20MG

Tirzepatide is an advanced dual-agonist peptide designed to engage the GLP-1 and GIP receptor pathways simultaneously. This coordinated incretin mechanism gives researchers a comprehensive model for exploring glucose regulation, insulin signalling, appetite pathways, lipid metabolism and body-composition models.

The larger 20 mg format provides additional flexibility for extended protocols, concentration-response research and comparison with single-agonist GLP-1 compounds or triple-agonist peptides.

Choice Peptides Tirzepatide 20 mg is supplied in a format selected for accurate measurement and consistent laboratory handling.

Form: Lyophilized peptide powder
Contents: 20 mg per vial
Purity: ≥99%
Testing: Meticulously tested for identity, quality and consistency
Storage: Keep in a cool, dry environment; refrigerate at 2°C–8°C after reconstitution.
Intended use: For laboratory research purposes only. Not for human or veterinary use.